Shares of early cancer-detection test maker Grail plunged 50% early Friday after a landmark U.K. study showed the test didn’t significantly reduce later-stage cancer cases. Grail said late Thursday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results